CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Revenue

CRISPR Therapeutics AG had revenue of $889.00K in the quarter ending September 30, 2025, with 47.67% growth. This brings the company's revenue in the last twelve months to $38.34M, down -81.10% year-over-year. In the year 2024, CRISPR Therapeutics AG had annual revenue of $37.31M, down -89.95%.

• Revenue (ttm): $38.34M
• Revenue Growth: -81.10%
• P/S Ratio: 125.11
• Revenue / Employee: $97,550
• Employees: 393
• Market Cap: 5.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	37.31M	-333.89M	-89.95%
Dec 31, 2023	371.21M	370.01M	30,885.48%
Dec 31, 2022	1.20M	-913.77M	-99.87%
Dec 31, 2021	914.96M	914.24M	127,154.94%
Dec 31, 2020	719.00K	-288.87M	-99.75%
Dec 31, 2019	289.59M	286.47M	9,169.85%
Dec 31, 2018	3.12M	-37.87M	-92.38%
Dec 31, 2017	41.00M	35.83M	693.90%
Dec 31, 2016	5.16M	4.92M	1,990.69%
Dec 31, 2015	247.00K	-	-
Dec 31, 2014	-	-	-